# A Study in Korean Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab

> **NCT01457950** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 135 (actual)

## Conditions studied

- Osteoporosis, Postmenopausal

## Interventions

- **DRUG:** denosumab
- **DRUG:** placebo
- **DRUG:** open-label denosumab

## Key facts

- **NCT ID:** NCT01457950
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-12
- **Final completion:** 2013-06
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2014-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01457950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01457950, "A Study in Korean Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01457950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*